MacroGenics Inc
MGNX
NASDAQ
Biotechnology
$4.22
USD
+0.14 (+3.43%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $259.34M
Volume 851.4K
Revenue
$157.08M
TTM
+2.0%
YoY
Gross Margin
74%
TTM
-17.2%
YoY
Net Income
$-70.36M
TTM
-26.1%
YoY
Operating Cash Flow
$-69.96M
TTM
-0.5%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 13.2 | 22.2 | 72.8 | 41.2 | 20.8 |
YoY Growth | +44.9% | +106.0% | -34.2% | +113.0% | +57.5% |
Cost of Revenue | 5.4 | 8.9 | 11.6 | 10.1 | 9.5 |
Gross Profit | 7.8 | 13.3 | 61.3 | 31.1 | 11.2 |
Selling, General & Administrative | 10.7 | 9.3 | 9.9 | 9.2 | 9.7 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 50.4 | 50.1 | 42.6 | 43.2 | 44.7 |
Operating Income | -42.6 | -36.8 | 18.6 | -12.1 | -33.4 |
EBITDA | -40.9 | -34.9 | 20.4 | -10.4 | -31.8 |
Other Income / Expense | 0.0 | 1.4 | 1.5 | 1.4 | 0.0 |
Total Other Income / Expense | 1.6 | 0.6 | -1.8 | -2.8 | -3.3 |
Income Before Income Taxes | -41.0 | -36.1 | 16.8 | -14.9 | -36.8 |
Income Taxes | 0.0 | 0.1 | 0.0 | -0.8 | 0.0 |
Net Income | -41.0 | -36.3 | 16.8 | -14.2 | -36.8 |
Consolidated Net Income / Loss | -41.0 | -36.3 | 16.8 | -14.2 | -36.8 |
Net Income Attributable to Common Shareholders | -41.0 | -36.3 | 16.8 | -14.2 | -36.8 |
Basic EPS | -$0.65 | -$0.57 | $0.27 | -$0.22 | -$0.58 |
Diluted EPS | -$0.65 | -$0.57 | $0.27 | -$0.22 | -$0.58 |
Basic Shares Outstanding | 63.0M | 63.1M | 63.2M | 63.3M | 63.4M |
Diluted Shares Outstanding | 63.0M | 63.1M | 63.3M | 63.2M | 63.4M |